Patent · US Expired

Certain antihypertensive 1-[2-[3-carbamoyl-4-hydroxy phenoxy]alkylene amino]-heterocyclic phenoxy-propanol derivatives

US4559354A · kind A · utility

11Cited by
2References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 6, 1983
Grant dateDec 17, 1985
Priority date
Expiry dateMay 6, 2003

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D307/46
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The invention relates to novel substituted phenyl ethers of the formula ##STR1## in which Ar represents a mono- or bi-cyclic carbocyclic aryl radical, or a mono- or bi-cyclic heterocyclic aryl radical bonded to a phenylene radical by way of a ring carbon atom, PA0 Ph represents a phenylene radical, PA0 n has the value 0 to 1 and PA0 alk represents alkylene having from 2 to 5 carbon atoms, the nitrogen atom and the oxygen atom or, if n is 0, the aromatic radical being separated from each other by at least two carbon atoms in the unbranched chain, and PA0 R.sub.1 and R.sub.2 each represents, independently of the other, hydrogen or lower alkyl, or together represent lower alkylene, oxa-lower alkylene, thia-lower alkylene, aza-lower alkylene or N-lower alkyl-aza-lower alkylene, and salts thereof, especially pharmaceutically acceptable non-toxic acid addition salts. Such compounds possess, on the one hand, blocking properties towards .beta.-adrenergic receptors and can therefore be used as .beta.-receptor-blockers with or without cardioselectivity for the treatment of Angina pectoris, hypertrophic cardiomyopathy and heart rhythm disorders and also as blood-pressure-reducing agents. On t…

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.